Study guide
2.2 Dosing Regimens, Days Supply & Pediatric/Geriatric Calculations
PEBC Pharmacy Technician Qualifying Examination Part I MCQ
Track your progress as you read
Finished sections get a check mark.
1 Introduction: PEBC Technician Qualifying Exam Part I Overview
0.1 Exam Facts, 2026 Blueprint & Test-Taking Strategy
2 Chapter 1: Prescription Intake, Adjudication & Processing
1.1 Prescription Legal Validity, Essential Elements & Order Intake 1.2 Patient Profile Setup, Drug Insurance & Third-Party Adjudication 1.3 Order Clarification, Refill Authorizations & Prescription Transfers
3 Chapter 2: Pharmaceutical Calculations for Pharmacy Practice
2.1 Metric Conversions, Ratio Strengths & Percentage Concentrations 2.2 Dosing Regimens, Days Supply & Pediatric/Geriatric Calculations 2.3 Alligation Alternate & Concentration Adjustments 2.4 IV Flow Rates, Infusion Times & Electrolyte Solutions
4 Chapter 3: Non-Sterile Compounding & NAPRA Standards
3.1 NAPRA Non-Sterile Standards, Facilities & Equipment Requirements 3.2 Master Formulation Records, Compounding Procedures & Beyond-Use Dates 3.3 Hazardous Non-Sterile Handling & Quality Assurance
5 Chapter 4: Sterile Compounding & Aseptic Technique
4.1 Cleanroom Engineering Controls, ISO Classifications & Airflow Workstations 4.2 Aseptic Technique, Hand Hygiene & Garbing Protocols 4.3 Parenteral Admixtures, Reconstitution & Sterile Beyond-Use Dates
6 Chapter 5: Product Release, Verification & Dispensing Systems
5.1 Technical Verification & Independent Double Checks 5.2 Final Product Inspection, Packaging & Auxiliary Labelling 5.3 Automated Dispensing Cabinets, Unit-Dose Systems & Technology 5.4 Patient Handover, Identity Verification & Technical Device Demonstrations
7 Chapter 6: Inventory Control, Cold Chain & Drug Distribution
6.1 Inventory Management, Ordering & Stock Rotation (FIFO) 6.2 Cold Chain Management, Temperature Monitoring & Excursion Protocols 6.3 Drug Recalls, Quarantine Protocols & Safe Disposal
8 Chapter 7: Patient Care & Clinical Support for Pharmacy Technicians
7.1 Patient Data Collection & Best Possible Medication History (BPMH) 7.2 Screening for Drug Therapy Problems & Pharmacist Referral Triggers 7.3 Compliance Packaging, Adherence Aids & Patient Support 7.4 Physical Measurements, Point-of-Care Testing & Supporting Medication Administration
9 Chapter 8: Canadian Pharmacy Legislation & Regulatory Framework
8.1 Canadian Federal Legislation: Food and Drugs Act & CDSA 8.2 Controlled Substances: The Controlled Substances Regulations, Narcotics, Controlled Drugs, Targeted Substances & Cannabis 8.3 Provincial Colleges of Pharmacy, Technician Scope of Practice & Privacy Laws
10 Chapter 9: Patient Safety, Continuous Quality Improvement & Ethics
9.1 Medication Incident Reporting, Root Cause Analysis & Continuous Quality Improvement 9.2 Error Prevention Strategies, High-Alert Medications & LASA Safeguards 9.3 Code of Ethics, Confidentiality & Professional Boundaries 9.4 Equity, Diversity, Inclusion & Cultural Safety in Pharmacy Practice
11 Chapter 10: Pharmacology Foundations, Communication & Public Health
10.1 Key Canadian Drug Classes, Common Indications & Canadian Brand/Generic Names 10.2 Evidence-Informed Decision Making & Authoritative Drug Information References 10.3 Interprofessional Collaboration, Effective Communication & Documentation Standards 10.4 Public Health Promotion, Harm Reduction & Community Wellness Programs
2.2 Dosing Regimens, Days Supply & Pediatric/Geriatric Calculations
Key Takeaways Explain This Topic AI
Days supply determines third-party billing and adherence monitoring; it is calculated by dividing total quantity dispensed by the maximum daily dose (MDD), rounding down to whole days for claim submissions.
Standard dispensing conventions apply to special dosage forms: eye and ear drops use 20 drops per millilitre unless another factor is given, metered-dose inhalers count labelled actuations, and insulin calculations add the pen's priming dose per injection when stated.
Pediatric dosing is primarily calculated on a weight-based scale (mg/kg/day divided into scheduled intervals) and must always be cross-checked against established safe dosage limits.
Body surface area (BSA), calculated via the Mosteller formula (square root of [height in cm * weight in kg / 3600]), provides superior dosing accuracy for chemotherapeutic agents and narrow therapeutic index pediatric therapies.
Geriatric dosage adjustments depend on estimated renal function using the Cockcroft-Gault creatinine clearance formula; serum creatinine alone often underestimates renal decline due to age-related muscle mass loss.
Last updated: September 2026
Dosing Regimens, Days Supply & Pediatric/Geriatric Calculations
In Canadian pharmacy practice, ensuring the safety of a medication regimen involves verifying that the prescribed dose, frequency, and duration are clinically appropriate for the patient's age, weight, and organ function. Pharmacy technicians must master dosing conversions and days supply calculations to ensure therapeutic safety and accurate provincial or third-party drug insurance billing.
Dosing Regimens & Frequency Interpretation
A dosing regimen specifies the quantity of drug (dose), the route of administration, and the dosing frequency. Technicians must understand standard prescription Latin abbreviations while upholding ISMP Canada standards that discourage ambiguous notations.
Frequency Abbreviations & Daily Multipliers
- Abbreviation Latin Term Meaning Doses per Day (Daily Multiplier)
- Daily semel in die Once daily (Avoid 'QD') 1
- BID bis in die Twice daily 2
- TID ter in die Three times daily 3
- QID quater in die Four times daily 4
- Q4H quaque 4 hora Every 4 hours 6 (24 hours / 4 hours)
- Q6H quaque 6 hora Every 6 hours 4 (24 hours / 6 hours)
- Q8H quaque 8 hora Every 8 hours 3 (24 hours / 8 hours)
- Q12H quaque 12 hora Every 12 hours 2 (24 hours / 12 hours)
- PRN pro re nata As needed Calculate using maximum daily limit
- Liquid Volume Dosing
Liquid oral suspensions and solutions are expressed in concentration ratios (e.g., 125 mg / 5 mL 125\text{ mg} / 5\text{ mL} 125 mg /5 mL , 250 mg / 5 mL 250\text{ mg} / 5\text{ mL} 250 mg /5 mL , 400 mg / 5 mL 400\text{ mg} / 5\text{ mL} 400 mg /5 mL ). To calculate the volume per dose: Volume per Dose (mL) = Dose Ordered (mg) Concentration on Hand (mg) × Volume of Hand Concentration (mL) \text{Volume per Dose (mL)} = \frac{\text{Dose Ordered (mg)}}{\text{Concentration on Hand (mg)}} \times \text{Volume of Hand Concentration (mL)} Volume per Dose (mL) = Concentration on Hand (mg) Dose Ordered (mg) × Volume of Hand Concentration (mL) Total Volume to Dispense (mL) = Volume per Dose (mL) × Doses per Day × Number of Days \text{Total Volume to Dispense (mL)} = \text{Volume per Dose (mL)} \times \text{Doses per Day} \times \text{Number of Days} Total Volume to Dispense (mL) = Volume per Dose (mL) × Doses per Day × Number of Days
Days Supply Calculations
The days supply indicates how long a dispensed quantity of medication will last when taken exactly as directed. In Canadian community practice, entering an inaccurate days supply can lead to third-party audit clawbacks, premature refill rejections, or patient under-dosing.
1. Solid Oral Dosage Forms (Tablets and Capsules) Days Supply = Total Number of Units Dispensed Units per Dose × Doses per Day \text{Days Supply} = \frac{\text{Total Number of Units Dispensed}}{\text{Units per Dose} \times \text{Doses per Day}} Days Supply = Units per Dose × Doses per Day Total Number of Units Dispensed
PRN Rule: For "as needed" prescriptions (e.g., "1 to 2 tablets PO Q4-6H PRN pain"), calculate days supply using the maximum possible daily consumption (Maximum Daily Dose, MDD):
- Maximum single dose = 2 tablets
- Maximum frequency = every 4 hours = 6 times per day
- Maximum daily dose = 2 × 6 = 12 tablets/day 2 \times 6 = 12\text{ tablets/day} 2 × 6 = 12 tablets/day
If 60 tablets are dispensed: Days Supply = 60 / 12 = 5 days \text{Days Supply} = 60 / 12 = 5\text{ days} Days Supply = 60/12 = 5 days .
2. Metered-Dose Inhalers (MDIs)
Inhalers are manufactured with a specific number of metered sprays (actuations) listed on the packaging (e.g., 120 or 200 actuations): Days Supply = Total Labeled Actuations Puffs per Dose × Doses per Day \text{Days Supply} = \frac{\text{Total Labeled Actuations}}{\text{Puffs per Dose} \times \text{Doses per Day}} Days Supply = Puffs per Dose × Doses per Day Total Labeled Actuations
Worked Example: A patient is prescribed Flovent HFA 125 mcg (fluticasone propionate) MDI, containing 120 metered actuations. Sig: 2 puffs BID.
Daily puffs: 2 × 2 = 4 puffs/day 2 \times 2 = 4\text{ puffs/day} 2 × 2 = 4 puffs/day .
Days supply: 120 / 4 = 30 days 120 / 4 = 30\text{ days} 120/4 = 30 days .
3. Ophthalmic and Otic Drops
Pharmacy calculations conventionally use 20 drops per millilitre (20 gtt/mL) for eye and ear drops unless the question or the product gives a different drop size. Real droppers vary, so use the factor the question gives: Total Drops in Container = Bottle Volume (mL) × 20 drops/mL \text{Total Drops in Container} = \text{Bottle Volume (mL)} \times 20\text{ drops/mL} Total Drops in Container = Bottle Volume (mL) × 20 drops/mL Days Supply = Total Drops in Container Drops per Administration × Administrations per Day × Number of Affected Eyes/Ears \text{Days Supply} = \frac{\text{Total Drops in Container}}{\text{Drops per Administration} \times \text{Administrations per Day} \times \text{Number of Affected Eyes/Ears}} Days Supply = Drops per Administration × Administrations per Day × Number of Affected Eyes/Ears Total Drops in Container
Important Abbreviations:
- OD ( oculus dexter ): Right eye
- OS ( oculus sinister ): Left eye
- OU ( oculus uterque ): Both eyes
Worked Example: Latanoprost 0.005% ophthalmic solution, one 2.5 mL bottle. Sig: 1 drop OU once daily at bedtime.
Total drops: 2.5 mL × 20 drops/mL = 50 drops 2.5\text{ mL} \times 20\text{ drops/mL} = 50\text{ drops} 2.5 mL × 20 drops/mL = 50 drops .
Daily drops: 1 drop × \times × 2 eyes (OU) × \times × 1 time/day = 2 drops/day.
Days supply: 50 / 2 = 25 days 50 / 2 = 25\text{ days} 50/2 = 25 days .
4. Insulin Calculations & Priming Units
Most insulin products in Canada are U-100 (100 units/mL) . Concentrated insulins also exist, such as insulin glargine 300 units/mL (Toujeo), insulin lispro 200 units/mL (Humalog 200 KwikPen) and regular insulin U-500. Always read the concentration on the pen or vial. For U-100 products:
10 mL Vial = 10 mL × 100 units/mL = 1 , 000 units 10\text{ mL} \times 100\text{ units/mL} = 1,000\text{ units} 10 mL × 100 units/mL = 1 , 000 units .
3 mL Cartridge or Prefilled Pen = 3 mL × 100 units/mL = 300 units 3\text{ mL} \times 100\text{ units/mL} = 300\text{ units} 3 mL × 100 units/mL = 300 units .
Box of 5 Pens (5 x 3 mL) = 1 , 500 units 1,500\text{ units} 1 , 500 units .
Pen Priming (Safety Test) Rule: Manufacturer instructions for most insulin pens (e.g., KwikPen, SoloSTAR, FlexTouch) direct a 2-unit priming dose (safety test) before each injection to confirm needle flow and clear air. Some pens specify a different amount, so check the pen's instructions. When a question states the priming amount, add it to each injection when calculating days supply. Total Daily Insulin Usage = ( Dose Units per Injection + 2 Priming Units ) × Injections per Day \text{Total Daily Insulin Usage} = (\text{Dose Units per Injection} + 2\text{ Priming Units}) \times \text{Injections per Day} Total Daily Insulin Usage = ( Dose Units per Injection + 2 Priming Units ) × Injections per Day Days Supply = Total Units Dispensed Total Daily Insulin Usage \text{Days Supply} = \frac{\text{Total Units Dispensed}}{\text{Total Daily Insulin Usage}} Days Supply = Total Daily Insulin Usage Total Units Dispensed
Worked Example: A patient injects Humalog (insulin lispro U-100) 18 units TID before meals. The pharmacy dispenses one box of five 3 mL prefilled pens (1,500 units total).
Usage per injection: 18 units (dose) + 2 units (prime) = 20 units 18\text{ units (dose)} + 2\text{ units (prime)} = 20\text{ units} 18 units (dose) + 2 units (prime) = 20 units .
Daily usage: 20 units × 3 injections/day = 60 units/day 20\text{ units} \times 3\text{ injections/day} = 60\text{ units/day} 20 units × 3 injections/day = 60 units/day .
Days supply: 1 , 500 units / 60 units/day = 25 days 1,500\text{ units} / 60\text{ units/day} = 25\text{ days} 1 , 500 units /60 units/day = 25 days .
Pediatric Weight-Based Dosing
Children have immature organ systems, varying metabolic rates, and distinct body composition. Most pediatric drug dosages are calculated based on body weight in kilograms ( mg/kg/day \text{mg/kg/day} mg/kg/day or mg/kg/dose \text{mg/kg/dose} mg/kg/dose ).
Step-by-Step Weight-Based Calculation Workflow
Convert weight from pounds to kilograms by dividing by 2.2.
Calculate the total daily dose (mg/day): Total Daily Dose (mg) = Weight (kg) × Dose Rate (mg/kg/day) \text{Total Daily Dose (mg)} = \text{Weight (kg)} \times \text{Dose Rate (mg/kg/day)} Total Daily Dose (mg) = Weight (kg) × Dose Rate (mg/kg/day)
Calculate the single unit dose (mg/dose): Single Dose (mg) = Total Daily Dose (mg) Doses per Day \text{Single Dose (mg)} = \frac{\text{Total Daily Dose (mg)}}{\text{Doses per Day}} Single Dose (mg) = Doses per Day Total Daily Dose (mg)
Convert the single dose to liquid volume (mL): Dose Volume (mL) = Single Dose (mg) Concentration (mg/mL) \text{Dose Volume (mL)} = \frac{\text{Single Dose (mg)}}{\text{Concentration (mg/mL)}} Dose Volume (mL) = Concentration (mg/mL) Single Dose (mg)
Safe Dose Verification: Always compare the calculated dose against the manufacturer's established maximum safe pediatric dose range. If the prescribed dose exceeds the maximum recommended limit, the technician must bring this to the pharmacist's immediate attention before dispensing.
Body Surface Area (BSA) Calculations
For antineoplastic agents, potent immunosuppressants, and critical care therapies, Body Surface Area ( m 2 \text{m}^2 m 2 ) correlates more reliably with cardiac output and glomerular filtration rate than body weight alone. In Canada, the Mosteller Formula is the clinical standard: BSA (m 2 ) = Height (cm) × Weight (kg) 3600 \text{BSA (m}^2\text{)} = \sqrt{\frac{\text{Height (cm)} \times \text{Weight (kg)}}{3600}} BSA (m 2 ) = 3600 Height (cm) × Weight (kg)
Worked Example: A pediatric patient is 120 cm tall and weighs 25 kg. Calculate the BSA: BSA = 120 × 25 3600 = 3000 3600 = 0.8333 ≈ 0.91 m 2 \text{BSA} = \sqrt{\frac{120 \times 25}{3600}} = \sqrt{\frac{3000}{3600}} = \sqrt{0.8333} \approx 0.91\text{ m}^2 BSA = 3600 120 × 25 = 3600 3000 = 0.8333 ≈ 0.91 m 2
If the prescribed antineoplastic dose is 50 mg/m 2 50\text{ mg/m}^2 50 mg/m 2 , the dose is: 50 mg/m 2 × 0.91 m 2 = 45.5 mg 50\text{ mg/m}^2 \times 0.91\text{ m}^2 = 45.5\text{ mg} 50 mg/m 2 × 0.91 m 2 = 45.5 mg .
Geriatric Dosage Considerations
Elderly patients experience progressive physiological decline, including decreased renal blood flow, reduced glomerular filtration rate (GFR), reduced liver enzyme activity, and loss of lean muscle mass. Because serum creatinine (SCr) is generated by muscle breakdown, an elderly patient with low muscle mass may have a deceptively "normal" serum creatinine level (e.g., 70 μ mol/L 70\ \mu\text{mol/L} 70 μ mol/L ) despite having clinically significant renal impairment.
Cockcroft-Gault Creatinine Clearance (CrCl) Equation
In Canadian hospital and ambulatory clinical practice, creatinine clearance is calculated using laboratory SI units ( μ mol/L \mu\text{mol/L} μ mol/L for serum creatinine): CrCl (mL/min) = ( 140 − Age ) × Weight (kg) × 1.23 Serum Creatinine ( μ mol/L) × ( 0.85 if female ) \text{CrCl (mL/min)} = \frac{(140 - \text{Age}) \times \text{Weight (kg)} \times 1.23}{\text{Serum Creatinine (}\mu\text{mol/L)}} \times (0.85\text{ if female}) CrCl (mL/min) = Serum Creatinine ( μ mol/L) ( 140 − Age ) × Weight (kg) × 1.23 × ( 0.85 if female )
(Note: When serum creatinine is reported in conventional US units of mg/dL, the formula is: CrCl = ( 140 − Age ) × Weight (kg) 72 × SCr (mg/dL) × [ 0.85 if female ] \text{CrCl} = \frac{(140 - \text{Age}) \times \text{Weight (kg)}}{72 \times \text{SCr (mg/dL)}} \times [0.85\text{ if female}] CrCl = 72 × SCr (mg/dL) ( 140 − Age ) × Weight (kg) × [ 0.85 if female ] ).
If the calculated CrCl is less than 50 mL/min 50\text{ mL/min} 50 mL/min or 30 mL/min 30\text{ mL/min} 30 mL/min , renally eliminated drugs (such as gabapentin, enoxaparin, ciprofloxacin, or novel oral anticoagulants) require downward dosage adjustments or extended dosing intervals to prevent toxic drug accumulation.